<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" id="no-js"><!-- InstanceBegin template="/Templates/ContentPage_Standard.dwt" codeOutsideHTMLIsLocked="false" -->

<head>
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<!-- InstanceBeginEditable name="title-tag" -->
<title>CDC - 2007 Isolation Precautions:Part 4 - HICPAC</title>
<!-- InstanceEndEditable --><!-- InstanceBeginEditable name="meta-data" -->
<meta name="Keywords" 		content="HICPAC, infection prevention and control guidelines and recommendation, Updating the Guideline Methodology, Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings, Guideline for the Prevention of Intravascular Catheter-Related Bloodstream Infections, BSI guidelines, Norovirus guidelines, Guideline for Prevention of Catheter-associated Urinary Tract Infections, UTI guidelines, Guideline for Disinfection and Sterilization in Healthcare Facilities, Disinfection and Sterilization Guidelines, Guideline for Isolation Precautions, Guideline for Hand Hygiene in Healthcare Settings, Guidance on Public Reporting of HAIs, Guideline for Preventing Healthcare-Associated Pneumonia, Guideline for the Prevention of Surgical Site Infection, SSI Guidelines, Management of Multidrug-Resistant Organisms In Healthcare Settings, MDRO, Guidance for Control of Infections with Carbapenem-Resistant or Carbapenemase-Producing Enterobacteriaceae in Acute Care Facilities, Guideline for Infection Control in Hospital Personnel,  Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program, Immunization of Health-Care Workers: Recommendations of ACIP and HICPAC, HICPAC current roster, healthcare, health departments, healthcare providers, antimicrobial, antibiotic-resistant, pathogens, Coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus species, Candida species, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter species, Acinetobacter baumannii, Klebsiella oxytoca, multidrug-resistant, Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococci (VRE) faecium, Carbapenem-resistant P. aeruginosa, Extended-spectrum cephalosporin-resistant K. pneumoniae, Carbapenem-resistant A. baumannii, VISA/VERS, Acinetobacter, Burkholderia cepacia, Clostridium sordellii, CDAD, CDI, Enterobacteriaceae (Carbapenem-resistance),Hepatitis, Klebsiella, MRSA, Mycobacterium abscessus, Norovirus, Staphylococcus aureus, Tuberculosis (TB),Vancomycin-intermediate Staphylococcus aureus, Vancomycin-resistant Staphylococcus aureus, Surgical Site Infection (SSI), Ventilator-associated Pneumonia (VAP), Ambulatory Settings, Ambulatory surgical centers, Dialysis Setting, Long-term care facilities (LTCFs), LTC " />
<meta name="DC.Subject" 	content="" />
<meta name="DC.Language" 	scheme="ISO 639-2" content="eng" />
<meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7" />
<!-- InstanceEndEditable --><!-- InstanceParam name="class" type="text" value="secondTier" --><!-- InstanceParam name="localFilesPath" type="text" value="/hicpac/" --><!-- InstanceParam name="content" type="boolean" value="true" --><!-- InstanceParam name="optionSpanish" type="boolean" value="false" --><!-- InstanceParam name="optionalFeatures" type="boolean" value="false" --><!-- InstanceParam name="optionalBreadCrumbs" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalSearch" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalA-Z" type="boolean" value="false" --><!-- InstanceParam name="optionalExtra" type="boolean" value="false" --><!-- InstanceParam name="JqueryUI" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiAccordion" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiCarousel" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiDatePicker" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiTabs" type="boolean" value="false" --><!-- InstanceParam name="dojoLibrary" type="boolean" value="false" -->

<meta http-equiv="content-type" content="text/html; charset=utf-8" />

<meta name="template.version" content="2.7.1.3" />
<!-- @package: TemplatePackage 'B' @version: "2.7.1.3" -->
<style type="text/css" media="screen">empty{color:#000};@import "https://hicpac//local/B/css/designview/designTime.css"/**/;</style>
<link rel="stylesheet" href="../../TemplatePackage/css/B/reset.css" type="text/css" media="screen" />
<link rel="stylesheet" href="../../TemplatePackage/css/B/newMods.css" type="text/css" media="screen" />
<link rel="stylesheet" href="../../TemplatePackage/css/B/print.css" type="text/css" media="print" />

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie6_fixes.css" />
<![endif]-->

<!--[if IE 7]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie7_fixes.css" />
<![endif]-->

<!--[if IE 8]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie8_fixes.css" />
<![endif]-->
<!-- /end compliance patch for microsoft browsers -->
<!-- JS below -->
<script type="text/javascript">(function(H){H.id=H.id.replace('no-','')})(document.documentElement)</script>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.watermark.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/common.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/startup.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/socialMedia.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/blocks-ie.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/video.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/navScripts.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/govdelivery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/anchor.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/syndicateThisPage.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/css-include.js"></script>
<script type="text/javascript" src="../../TemplatePackage/3.0/js/libs/moment/moment.min.js"></script>

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<script type="text/javascript" src="/TemplatePackage/js/B/pngfix.js"></script>
<script type="text/javascript" src="/TemplatePackage/js/B/blocks-ie6.js"></script>
<![endif]-->

<!--[if lte IE 8]>
<script type="text/javascript" src="/TemplatePackage/js/B/jquery.curvycorners.js"></script>
<![endif]-->

<script type="text/javascript" src="../../TemplatePackage/js/B/cdc-gridCompatibility.js"></script>

<link rel="shortcut icon" href="../../TemplatePackage/images/home/favicon.ico" />
<link rel="home" href="../../index.html" title="Home" />

<!-- Begin Survey scripts -->
<script type="text/javascript" src="../../JScript/foresee/foresee-trigger.js"></script>
<script type="text/javascript" src="../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->

<!-- InstanceBeginEditable name="local-css" -->
<style type="text/css" media="all">
@import "../local/B/css/local.css"/**/;
</style>
<script type="text/javascript" src="http://www.cdc.gov/news/scripts/govdelivery.js"></script>
<!--[if IE]>
<script defer language="javascript" type="text/javascript">
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
</script>
<![endif]-->
<!--[if ! IE]><!-->
<script language="javascript" type="text/javascript">
$().ready(function(){
		
		var cdcLeftNav = new CDC.LeftNav("nav-primary", location.pathname, true, true);
		cdcLeftNav.render();

});
</script>
<!--<![endif]-->

<!-- InstanceEndEditable -->
</head>
<body id="contentPageStandard" class="secondTier secondTier v270">

<div id="skipmenu">
	<a href="2007ip_part4.html#searchBox" class="skippy" title="Skip to search">Skip directly to search</a>
	<a href="2007ip_part4.html#az" class="skippy" title="Skip to A to Z list">Skip directly to A to Z list</a>
	<a href="2007ip_part4.html#nav" class="skippy" title="Skip to navigation">Skip directly to navigation</a>
	<a href="2007ip_part4.html#content-main" class="skippy" title="Skip to content">Skip directly to site content</a>
	<a href="2007ip_part4.html#content-secondary" class="skippy" title="Skip to page options">Skip directly to page options</a>
</div>
<div id="wrapper">
	<div id="wrapper-inner">
		<div id="branding">
			<span id="homeward"><a href="../../index.html" title="Return to the CDC Home Page">CDC Home</a></span>
<div id="branding-logo">
	<div id="branding-logoImage"><img src="../../TemplatePackage/images/cdcHeaderLogo.gif" width="470" height="47" alt="CDC. Centers for Disease Control and Prevention. CDC 24/7: Saving Lives. Protecting People." border="0" /><a href="../../index.html" title="CDC 24/7: Saving Lives. Protecting People.&trade;"><span>CDC 24/7: Saving Lives. Protecting People.&trade;</span></a></div>

				<div id="searchForm" class="searchResize"><a name="search"></a>
		<form id="searchCDC" method="get" action="https://search.cdc.gov/search">
			<fieldset>
				<div id="cdc-Query">
					<label for="searchBox" class="overlabel search">Search The CDC</label>
					<input id="searchBox" class="searchBox" name="query" maxlength="256" type="text" />
				</div>
				<div id="cdc-Submit">
					<!-- label for="searchButton" class="searchButton">Search Button</label -->
					<input id="searchButton" class="searchButton" src="../../TemplatePackage/images/home/search_button.gif" name="searchButton" alt="Search" type="image" />
					<input name="action" value="search" type="hidden" />
				</div>
				<input type="hidden" name="utf8" value="&#x2713;"/>
				<input type="hidden" name="affiliate" value="cdc-main"/>
			</fieldset>
		</form>
	</div>
			</div>
<noscript>
<div class="noscript"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../Other/about_cdcgov.html" title="Browser requirements for CDC.gov">About CDC.gov</a>.</div>
</noscript>
<!--<div id="emergency-alert">
<h1></h1> 
<p></p>
<a href="#"></a>
</div>-->
		</div>
		
		<div id="content">
			<div id="topic-title"><!-- InstanceBeginEditable name="topic-title" -->
			<h2><a href="../index.html">Healthcare Infection Control Practices Advisory Committee (HICPAC)</a></h2>
			<!-- InstanceEndEditable -->
			</div>
			<div id="content-inner">
				<!-- ########## BREADCRUMBS START HERE ########## -->
				<!-- InstanceBeginEditable name="breadcrumbs" -->
			<div id="breadBox">
	<ul id="breadcrumbs">
		<li style="display:none;"></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
				<div id="socialMediaContainer">
	<div class="share_container noLinking">
	 	<a class="share_button_facebook" title="Facebook" href="2007ip_part4.html#"><span id="share_facebook" class="facebookRecommend"></span></a>
	 	<a class="share_button_twitter" title="Twitter" href="2007ip_part4.html#"><span id="share_twitter" class="twitterTweet"></span></a>
		<a class="share_button noLinking" href="2007ip_part4.html#socialMediaContainer"><img src="../../TemplatePackage/images/social/sm-plus.gif" alt="Share" /><span class="shareButtonEn">Share</span><span class="shareButtonEs">Compartir</span></a>
	</div>
</div>

				<div id="content-main">
					<div class="main-inner">
						<!-- InstanceBeginEditable name="content-main" -->
                        
                         <div class="syndicate">  
    <div class="mSyndicate">  
						<h1>2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings	</h1>
                  
                    <p> Download the complete PDF version  
                      <a href="https://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf">Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings 2007</a> <span class="genericLabel">PDF (3.80 MB / 225 pages)</span>
</p>
                        
						<div id="onthispage">
<div class="rounders grey bulleted-links">
<div class="inner">
<div class="t"></div>

<h4>On this Page</h4>
<div class="subc">
<ul>
<li><a href="2007ip_part4.html#1">I. Administrative Responsibilities</a></li>
      <li><a href="2007ip_part4.html#a2">II. Education and Training</a></li>
      <li><a href="2007ip_part4.html#a3">III.Surveillance</a></li>
      <li><a href="2007ip_part4.html#a4">IV. Standard Precautions</a></li>
      <li><a href="2007ip_part4.html#a5">V.Transmission-Based Precautions</a></li>
      <li><a href="2007ip_part4.html#a6">VI. Protective Environment</a> </li>
   
</ul>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>
              
               
   <p>These recommendations are designed to prevent transmission of infectious agents among patients and healthcare personnel in all settings where healthcare is delivered. As in other CDC/HICPAC guidelines, each recommendation is categorized on the basis of existing scientific data, theoretical rationale, applicability, and when possible, economic impact. The CDC/HICPAC system for categorizing recommendations is as follows: <br />

                    <strong> Category IA</strong> Strongly recommended for implementation and strongly supported by well-designed experimental, clinical, or epidemiologic studies.  <br />

                    <strong> Category IB </strong>Strongly recommended for implementation and supported by some experimental, clinical, or epidemiologic studies and a strong theoretical rationale. <br />

                    <strong> Category IC </strong>Required for implementation, as mandated by federal and/or state regulation or standard.  <br />

                    <strong> Category II </strong>Suggested for implementation and supported by suggestive clinical or epidemiologic studies or a theoretical rationale.  <br />

                    <strong> No recommendation;</strong> unresolved issue. Practices for which insufficient evidence or no consensus regarding efficacy exists.</p>   
  
  <p class="topOPage"><a href="2007ip_part4.html#">Top of Page</a></p>
  
   <h3 id="a1">I. Administrative Responsibilities</h3>
                   <p>Healthcare organization administrators should ensure the implementation of recommendations in this section.                     </p>
                   
                 <div class="margin">  <p>
                     I.A. Incorporate preventing transmission of infectious agents into the objectives of the organization's patient and occupational safety programs [543-546, 561, 620, 626, 946]. Category IB/IC
                     </p>
                     
                     <p>I.B. Make preventing transmission of infectious agents a priority for the healthcare organization. Provide administrative support, including fiscal and human resources for maintaining infection control programs [434, 548, 549, 559, 561, 566, 662 552, 562-564, 946]. Category IB/IC</p>
                   
                   <div class="margin">
                     <p> I.B.1. Assure that individuals with training in infection control are employed by or are available by contract to all healthcare facilities so that the infection control program is managed by one or more qualified individuals [552, 566 316, 575, 947 573, 576, 946]. Category IB/IC</p>
                     
                       <div class="margin">
                     <p> I.B.1.a. Determine the specific infection control full-time equivalents (FTEs) according to the scope of the infection control program, the complexity of the healthcare facility or system, the characteristics of the patient population, the unique or urgent needs of the facility and community, and proposed staffing levels based on survey results and recommendations from professional organizations [434, 549 552, 566 316, 569, 573, 575 948 949]. Category IB 
                       </p>
                       
                       </div>
                       <p>I.B.2. Include prevention of healthcare-associated infections (HAI) as one determinant of bedside nurse staffing levels and composition,
                     especially in high-risk units 585-589 590 592 593 551, 594, 595 418, 596, 597 583. 
                     Category IB</p>
                     
                       <p>I.B.3. Delegate authority to infection control personnel or their designees (e.g., patient care unit charge nurses) for making infection control decisions concerning patient placement and assignment of Transmission-Based Precautions 549 434, 857, 946. Category IC</p>
                       
                       <p> I.B.4. Involve infection control personnel in decisions on facility construction and design, determination of AIIR and Protective Environment capacity needs and environmental assessments [11, 13,  950 951 12]. Category IB/IC</p>
                     
                     
                     <div class="margin">
                       <p> I.B.4.a. Provide ventilation systems required for a sufficient number of AIIRs (as determined by a risk assessment) and Protective Environments in healthcare facilities that provide care to patients for whom such rooms are indicated, according to published recommendations [11-13, 15]. Category IB/IC</p>
                       
                     </div>
                     <p>I.B.5. Involve infection control personnel in the selection and post-implementation evaluation of medical equipment and supplies and changes in practice that could affect the risk of HAI [952, 953]. Category IC</p>
                     
                         <p> I.B.6. Ensure availability of human and fiscal resources to provide clinical microbiology laboratory support, including a sufficient number of medical technologists trained in microbiology, appropriate to the healthcare setting, for monitoring transmission of microorganisms, planning and conducting epidemiologic investigations, and detecting emerging pathogens. Identify resources for performing surveillance cultures, rapid diagnostic testing for viral and other selected pathogens, preparation of antimicrobial susceptibility summary reports, trend analysis, and molecular typing of clustered isolates (performed either on-site or in a reference laboratory) and use these resources according to facility-specific epidemiologic needs, in consultation with clinical microbiologists [553, 609, 610, 612, 617, 954 614 603, 615, 616 605 599 554 598, 606, 607]. Category IB</p>
                     
                         <p> I.B.7. Provide human and fiscal resources to meet occupational health needs related to infection control (e.g., healthcare personnel immunization, post-exposure evaluation and care, evaluation and management of healthcare personnel with communicable infections [739 12 17, 879-881, 955 134 690]. Category IB/IC</p>
                     
                         <p> I.B.8. In all areas where healthcare is delivered, provide supplies and equipment necessary for the consistent observance of Standard Precautions, including hand hygiene products and personal protective equipment (e.g., gloves, gowns, face and eye protection) [739 559 946]. Category IB/IC</p>
                     
                         <p>                           I.B.9. Develop and implement policies and procedures to ensure that reusable patient care equipment is cleaned and reprocessed [87 11], appropriately before use on another patient [11, 956 957, 958 959 836 960 961]. Category IA/IC</p>
                           
                   </div>
                       <p>I.C. Develop and implement processes to ensure oversight of infection control activities appropriate to the healthcare setting and assign responsibility for oversight of infection control activities to an individual or group within the healthcare organization that is knowledgeable about infection control [434, 549, 566]. Category II
                   </p>
                   
                       <p>I.D. Develop and implement systems for early detection and management (e.g., use of appropriate infection control measures, including isolation precautions, PPE) of potentially infectious persons at initial points of patient encounter in outpatient settings (e.g., triage areas, emergency departments, outpatient clinics, physician offices) and at the time of admission to hospitals and long-term care facilities (LTCF) [9, 122, 134, 253, 827]. Category IB</p>
                   
                       <p> I.E. Develop and implement policies and procedures to limit patient visitation by persons with signs or symptoms of a communicable infection. Screen visitors to high-risk patient care areas (e.g., oncology units, hematopoietic stem call transplant [HSCT] units, intensive care units, other severely immunocompromised patients) for possible infection [43 24, 41, 962, 963]. Category IB</p>
                       
                       <p>I.F. Identify performance indicators of the effectiveness of organization-specific measures to prevent transmission of infectious agents (Standard and Transmission-Based Precautions), establish processes to monitor adherence to those performance measures and provide feedback to staff  members [704 739 705 708 666, 964 667 668 555]. Category IB </p>
                      
                       
                 </div>
   
   <p class="topOPage"><a href="2007ip_part4.html#">Top of Page</a></p>
   
<h3 id="a2">II. Education and Training</h3>
                  <div class="margin"> 
                <p>  II.A. Provide job- or task-specific education and training on preventing transmission of infectious agents associated with healthcare during orientation to the healthcare facility; update information periodically during ongoing education programs. Target all healthcare personnel for education and training, including but not limited to medical, nursing, clinical technicians, laboratory staff; property service (housekeeping), laundry, maintenance and dietary workers; students, contract staff and volunteers. Document competency initially and repeatedly, as appropriate, for the specific staff positions. Develop a system to ensure that healthcare personnel employed by outside agencies meet these education and training requirements through programs offered by the agencies or by participation in the healthcare facility's program designed for full-time personnel [126, 559, 561, 562, 655, 681-684, 686, 688, 689, 702, 893, 919, 965]. Category IB</p>
                   <div class="margin"> 
                <p> 
                  II.A.1. Include in education and training programs, information concerning use of vaccines as an adjunctive infection control measure [17, 611, 690, 874]. Category IB</p>
                  
                <p> II.A.2. Enhance education and training by applying principles of adult learning, using reading level and language appropriate material for the target audience, and using online educational tools available to the institution [658, 694, 695, 697, 698, 700, 966]. Category IB</p>
                  
                   </div>
                 <p> II.B. Provide instructional materials for patients and visitors on recommended hand hygiene and Respiratory Hygiene/Cough Etiquette practices and the application of Transmission-Based Precautions [9, 709, 710, 963]. Category II
                  </p>
                  
                  </div>
    
    <p class="topOPage"><a href="2007ip_part4.html#">Top of Page</a></p>
    
     <h3 id="a3">III.Surveillance</h3>
                  
                  <div class="margin">
                  <p>III.A. Monitor the incidence of epidemiologically-important organisms and targeted HAIs that have substantial impact on outcome and for which effective preventive interventions are available; use information collected through surveillance of high-risk populations, procedures, devices and highly transmissible infectious agents to detect transmission of infectious  agents in the healthcare facility [566, 671, 672, 675, 687, 919, 967, 968 673 969 970].  Category IA 
                    </p>
                    
                  <p>III.B. Apply the following epidemiologic principles of infection surveillance [671, 967 673 969 663 664]. Category IB </p>
                    
                  <ul>
                    <li>Use standardized definitions of infection </li>
                    <li> Use laboratory-based data (when available) </li>
                    <li> Collect epidemiologically-important variables (e.g., patient locations 
                      and/or clinical service in hospitals and other large multi-unit facilities, population-specific risk factors [e.g., low birth-weight neonates], underlying conditions that predispose to serious adverse outcomes) 
                      </li>
                    <li> Analyze data to identify trends that may indicated increased rates of transmission 
                      </li>
                    <li>Feedback information on trends in the incidence and prevalence of HAIs, probable risk factors, and prevention strategies and their impact to the appropriate healthcare providers, organization administrators, and as required by local and state health authorities</li>
                  </ul>
                  
                  <p> III.C. Develop and implement strategies to reduce risks for transmission and 
                    evaluate effectiveness [566, 673, 684, 970 963 971]. Category IB</p>
                    
                  <p> III.D. When transmission of epidemiologically-important organisms continues despite implementation and documented adherence to infection prevention and control strategies, obtain consultation from persons knowledgeable in infection control and healthcare epidemiology to review the situation and recommend additional measures for control [566 247 687]. Category IB</p>
                  
                  <p> III.E. Review periodically information on community or regional trends in the incidence and prevalence of epidemiologically-important organisms (e.g., influenza, RSV, pertussis, invasive group A streptococcal disease, MRSA, VRE) (including in other healthcare facilities) that may impact transmission of organisms within the facility [398, 687, 972, 973 974]. Category II </p>
                  
                  </div>
     
     <p class="topOPage"><a href="2007ip_part4.html#">Top of Page</a></p>
     
      <h3 id="a4">IV. Standard Precautions</h3>
                  <p>Assume that every person is potentially infected or colonized with an organism that could be transmitted in the healthcare setting and apply the following infection control practices during the delivery of health care.                  </p>
                  
                   <div class="margin">
                  <p>IV.A. Hand Hygiene</p>
                  
                  <div class="margin">
                    <p>    
                    IV.A.1. During the delivery of healthcare, avoid unnecessary touching of surfaces in close proximity to the patient to prevent both contamination of clean hands from environmental surfaces and transmission of pathogens from contaminated hands to surfaces [72,
                    73 739, 800, 975]{CDC, 2001 #970. Category IB/IC 
                    </p>
                    
                    <p>IV.A.2. When hands are visibly dirty, contaminated with proteinaceous material, or visibly soiled with blood or body fluids, wash hands with either a nonantimicrobial soap and water or an antimicrobial soap and water [559]. Category IA 
                    </p>
                    
                    <p>IV.A.3. If hands are not visibly soiled, or after removing visible material with nonantimicrobial soap and water, decontaminate hands in the clinical situations described in IV.A.2.a-f. The preferred method of hand decontamination is with an alcohol-based hand rub 562, 978. Alternatively, hands may be washed with an antimicrobial soap and water. Frequent use of alcohol-based hand rub immediately following handwashing with nonantimicrobial soap may increase the frequency of dermatitis 559. Category IB Perform hand hygiene: 
                    </p>
                    
                    <div class="margin">
                    <p>IV.A.3.a. Before having direct contact with patients [664, 979]. Category IB
                    </p>
                    
                    <p>IV.A.3.b. After contact with blood, body fluids or excretions, mucous membranes, nonintact skin, or wound dressings [664]. Category IA
                    </p>
                    
                    <p>IV.A.3.c. After contact with a patient's intact skin (e.g., when taking a pulse or blood pressure or lifting a patient) [167, 976, 979, 980].
                    Category IB</p>
                    
                    <p>IV.A.3.d. If hands will be moving from a contaminated-body site to a clean-body site during patient care. Category II</p>
                    
                    <p>IV.A.3.e. After contact with inanimate objects (including medical equipment) in the immediate vicinity of the patient [72, 73, 88, 800, 981
                      982]. Category II</p>
                      
                    <p>IV.A.3.f. After removing gloves [728, 741, 742]. Category IB </p>
                    
                    </div>
                   <p>IV.A.4. Wash hands with non-antimicrobial soap and water or with antimicrobial soap and water if contact with spores (e.g., <em>C. difficile</em> or Bacillus anthracis) is likely to have occurred. The physical action of washing and rinsing hands under such circumstances is recommended because alcohols, chlorhexidine, iodophors, and other antiseptic agents have poor activity against spores [559, 956, 983].
                    Category II</p>
                    
                   <p>IV.A.5. Do not wear artificial fingernails or extenders if duties include direct contact with patients at high risk for infection and associated adverse outcomes (e.g., those in ICUs or operating rooms) [30, 31, 559, 722-724]. Category IA</p>
                     
                   
                   
                   <div class="margin">
                   <p> IV.A.5.a. Develop an organizational policy on the wearing of non-natural nails by healthcare personnel who have direct contact with patients outside of the groups specified above 984. Category II </p>
                   </div>
                  </div>
                    <p>IV.B. Personal protective equipment (PPE) (see Figure)</p>
                   
                   
                  <div class="margin"> 
                    <p>
                    IV.B.1. Observe the following principles of use:</p>
                    
                    
                    <div class="margin"> 
                    <p> IV.B.1.a. Wear PPE, as described in IV.B.2-4,when the nature of the anticipated patient interaction indicates that contact with blood or body fluids may occur [739, 780, 896]. Category IB/IC</p>
                    <p> IV.B.1.b. Prevent contamination of clothing and skin during the process of removing PPE (see Figure). Category II</p>
                    <p> IV.B.1.c. Before leaving the patient's room or cubicle, remove and discard PPE 18, 739. Category IB/IC </p>
                    </div>
                      
                     <p> IV.B.2. Gloves</p>
                     
                     <div class="margin"> 
                     <p> IV.B.2.a. Wear gloves when it can be reasonably anticipated that contact with blood or other potentially infectious materials, mucous membranes, nonintact skin, or potentially contaminated intact skin (e.g., of a patient incontinent of stool or urine) could occur
                       [18, 728, 739, 741, 780, 985]. Category IB/IC</p>
                       
                     <p> IV.B.2.b. Wear gloves with fit and durability appropriate to the task 559, 731,
                       732, 739, 986, 987. Category IB</p>
                       
                       <div class="margin"> 
                     <p> IV.B.2.b.i. Wear disposable medical examination gloves for providing direct patient care.</p>
                     <p> IV.B.2.b.ii. Wear disposable medical examination gloves or reusable utility gloves for cleaning the environment or medical equipment.</p>
                     
                     
                     </div>
                     
                      <p> IV.B.2.c. Remove gloves after contact with a patient and/or the surrounding environment (including medical equipment) using proper technique to prevent hand contamination (see Figure). Do not wear the same pair of gloves for the care of more than one patient. Do not wash gloves for the purpose of reuse since this practice has been associated with transmission of pathogens [559, 728, 741-743, 988]. Category IB</p>
                      <p> IV.B.2.d. Change gloves during patient care if the hands will move from a contaminated body-site (e.g., perineal area) to a clean body-site (e.g., face). Category II 
                       </p>
                     </div>
                       <p>IV.B.3. Gowns</p>
                       <div class="margin"> 
                       <p> IV.B.3.a. Wear a gown, that is appropriate to the task, to protect skin and prevent soiling or contamination of clothing during procedures and patient-care activities when contact with blood, body fluids, secretions, or excretions is anticipated [739, 780, 896]. Category IB/IC</p>
                       
                       <div class="margin"> 
                       <p> IV.B.3.a.i. Wear a gown for direct patient contact if the patient has uncontained secretions or excretions ]24, 88, 89, 739, 744] Category IB/IC</p>
                       <p> IV.B.3.a.ii. Remove gown and perform hand hygiene before leaving the patient's environment [24, 88, 89, 739, 744] Category IB/IC</p>
                       </div>
                       
                       <p> IV.B.3.b. Do not reuse gowns, even for repeated contacts with the same patient. Category II</p>
                       <p> IV.B.3.c. Routine donning of gowns upon entrance into a high risk unit (e.g., ICU, NICU, HSCT unit) is not indicated [365, 747-750]. Category IB</p>
                      </div> 
                    <p> IV.B.4. Mouth, nose, eye protection</p>
                      
                       <div class="margin"> 
                       <p> IV.B.4.a. Use PPE to protect the mucous membranes of the eyes, nose and mouth during procedures and patient-care activities that are likely to generate splashes or sprays of blood, body fluids, secretions and excretions. Select masks, goggles, face shields, and combinations of each according to the need anticipated by the task performed [113, 739, 780, 896]. Category IB/IC</p>
                       </div>
                       
                       <p> IV.B.5. During aerosol-generating procedures (e.g., bronchoscopy, suctioning of the respiratory tract [if not using in-line suction catheters], endotracheal intubation) in patients who are not suspected of being infected with an agent for which respiratory protection is otherwise recommended (e.g., M. tuberculosis, SARS or hemorrhagic fever viruses), wear one of the following: a face shield that fully covers the front and sides of the face, a mask with attached shield, or a mask and goggles (in addition to gloves and gown) [95, 96, 113, 126 93 94, 134]. Category IB</p>
                  </div>
                    <p>
                     IV.C. Respiratory Hygiene/Cough Etiquette</p>
                     
                     <div class="margin"> 
                    <p> IV.C.1. Educate healthcare personnel on the importance of source control measures to contain respiratory secretions to prevent droplet and fomite transmission of respiratory pathogens, especially during seasonal outbreaks of viral respiratory tract infections (e.g., influenza, RSV, adenovirus, parainfluenza virus) in communities 14,
                      24, 684 10, 262. Category IB</p>
                      
                      
                    <p> IV.C.2. Implement the following measures to contain respiratory secretions in patients and accompanying individuals who have signs and symptoms of a respiratory infection, beginning at the point of initial encounter in a healthcare setting (e.g., triage, reception and waiting areas in emergency departments, outpatient clinics and physician
                      offices) 20, 24, 145, 902, 989.</p>
                      
                      <div class="margin"> 
                    <p> IV.C.2.a. Post signs at entrances and in strategic places (e.g., elevators, cafeterias) within ambulatory and inpatient settings with instructions to patients and other persons with symptoms of a respiratory infection to cover their mouths/noses when coughing or sneezing, use and dispose of tissues, and perform hand hygiene after hands have been in contact with respiratory secretions. Category II</p>
                    <p>IV.C.2.b. Provide tissues and no-touch receptacles (e.g.,foot-pedaloperated
                      lid or open, plastic-lined waste basket) for disposal of tissues 20. Category II</p>
                    <p> IV.C.2.c. Provide resources and instructions for performing hand hygiene in or near waiting areas in ambulatory and inpatient settings; provide conveniently-located dispensers of alcohol-based hand rubs and, where sinks are available, supplies for handwashing
                      [559, 903]. Category IB</p>
                      
                    <p> IV.C.2.d. During periods of increased prevalence of respiratory infections in the community (e.g., as indicated by increased school absenteeism, increased number of patients seeking care for a
                      respiratory infection), offer masks to coughing patients and other symptomatic persons (e.g., persons who accompany ill patients) upon entry into the facility or medical office [126, 899 898] and encourage them to maintain special separation, ideally a distance of at least 3 feet, from others in common waiting areas
                      [23, 103, 111, 114 20, 134]. Category IB</p>
                      <div class="margin"> 
                    <p> IV.C.2.d.i. Some facilities may find it logistically easier to institute this recommendation year-round as a standard of practice. Category II</p>
                    </div>
                    </div>
                     </div>
                     
                    <p> IV.D. Patient placement</p>
                    
                    <div class="margin"> 
                    <p> IV.D.1. Include the potential for transmission of infectious agents in patient-placement decisions. Place patients who pose a risk for transmission to others (e.g., uncontained secretions, excretions or wound drainage; infants with suspected viral respiratory or gastrointestinal infections) in a single-patient room when available 
                      [24, 430, 435, 796, 797, 806, 990 410, 793]. Category IB</p>
                      
                    <p> IV.D.2. Determine patient placement based on the following principles:</p>
                    
                    <ul>
                      <li> Route(s) of transmission of the known or suspected infectious 
                      agent </li>
                      <li>Risk factors for transmission in the infected patient </li>
                      <li>Risk factors for adverse outcomes resulting from an HAI in other 
                        patients in the area or room being considered for patient- 
                      placement </li>
                      <li>Availability of single-patient rooms </li>
                      <li> Patient options for room-sharing (e.g., cohorting patients with 
                        the same infection) Category II 
                      </li>
                    </ul>
                    </div>
                     <p> IV.E. Patient-care equipment and instruments/devices 956</p>
                     
                     <div class="margin"> 
                       <p>IV.E.1. Establish policies and procedures for containing, transporting, and handling patient-care equipment and instruments/devices that may be contaminated with blood or body fluids [18, 739, 975]. Category IB/IC</p>
                       
                       <p> IV.E.2. Remove organic material from critical and semi-critical instrument/devices, using recommended cleaning agents before high level disinfection and sterilization to enable effective disinfection and sterilization processes [836 991, 992]. Category IA</p>
                       
                       <p> IV.E.3. Wear PPE (e.g., gloves, gown), according to the level of anticipated contamination, when handling patient-care equipment and instruments/devices that is visibly soiled or may have been in contact with blood or body fluids 18, 739, 975. Category IB/IC </p>
                       
                     </div>
                      
                      IV.F. Care of the environment 11 
                      
                      <div class="margin"> 
                        <p>IV.F.1. Establish policies and procedures for routine and targeted cleaning of environmental surfaces as indicated by the level of patient contact and degree of soiling [11]. Category II</p>
                        
                        <p> IV.F.2. Clean and disinfect surfaces that are likely to be contaminated with pathogens, including those that are in close proximity to the patient (e.g., bed rails, over bed tables) and frequently-touched surfaces in the patient care environment (e.g., door knobs, surfaces in and
                          surrounding toilets in patients' rooms) on a more frequent schedule compared to that for other surfaces (e.g., horizontal surfaces in
                          waiting rooms) [11 73, 740, 746, 993, 994 72, 800, 835 995]. Category IB</p>
                        
                        <p> IV.F.3. Use EPA-registered disinfectants that have microbiocidal (i.e., killing) activity against the pathogens most likely to contaminate the patient-care environment. Use in accordance with manufacturer's                          instructions 842-844, 956, 996
                        . Category IB/IC</p>
                        
                        <div class="margin"> 
                        <p> IV.F.3.a. Review the efficacy of in-use disinfectants when evidence of continuing transmission of an infectious agent (e.g., rotavirus, <em>C. difficile</em>, norovirus) may indicate resistance to the in-use product and change to a more effective disinfectant as indicated [275, 842,
                        847]. Category II</p>
                        
                        </div>
                        
                        <p> IV.F.4. In facilities that provide health care to pediatric patients or have waiting areas with child play toys (e.g., obstetric/gynecology offices and clinics), establish policies and procedures for cleaning and disinfecting toys at regular intervals [379 80]. Category IB</p>
                        
                        <ul>
                          <li>  Use the following principles in developing this policy and procedures: Category II </li>
                          <li>Select play toys that can be easily cleaned and disinfected </li>
                          <li> Do not permit use of stuffed furry toys if they will be shared </li>
                          <li> Clean and disinfect large stationary toys (e.g., climbing 
                            equipment) at least weekly and whenever visibly soiled </li>
                          <li> If toys are likely to be mouthed, rinse with water after disinfection; alternatively wash in a dishwasher 
                          </li>
                          <li> When a toy requires cleaning and disinfection, do so immediately or store in a designated labeled container separate from toys that are clean and ready for use.</li>
                        </ul>
                        <p> IV.F.5. Include multi-use electronic equipment in policies and procedures for preventing contamination and for cleaning and disinfection, especially those items that are used by patients, those used during delivery of patient care, and mobile devices that are moved in and out of patient rooms frequently (e.g., daily) [850 851, 852, 997]. Category IB</p>
                        
                        <div class="margin"> 
                        <p> IV.F.5.a. No recommendation for use of removable protective covers or washable keyboards. Unresolved issue</p>
                        
                        </div>
                     </div>
                     
                      <p>IV.G. Textiles and laundry
                      </p>
                      
                      <div class="margin"> 
                        <p>IV.G.1. Handle used textiles and fabrics with minimum agitation to avoid contamination of air, surfaces and persons [739, 998, 999]. Category IB/IC</p>
                        
                        <p> IV.G.2. If laundry chutes are used, ensure that they are properly designed, maintained, and used in a manner to minimize dispersion of aerosols from contaminated laundry [11, 13, 1000, 1001]. Category IB/IC 
                        </p>
                        
                      </div>
                      <p>IV.H. Safe injection practices The following recommendations apply to the use of needles, cannulas that replace needles, and, where applicable intravenous delivery systems 454</p>
                      
                     <div class="margin"> 
                      <p>IV.H.1. Use aseptic technique to avoid contamination of sterile injection equipment [1002, 1003]. Category IA</p>
                      
                      <p>IV.H.2. Do not administer medications from a syringe to multiple patients, even if the needle or cannula on the syringe is changed. Needles, cannulae and syringes are sterile, single-use items; they should not be reused for another patient nor to access a medication or solution that might be used for a subsequent patient 453, 919, 1004, 1005. 
                       Category IA</p>
                       
                      <p> IV.H.3. Use fluid infusion and administration sets (i.e., intravenous bags, tubing and connectors) for one patient only and dispose appropriately after use. Consider a syringe or needle/cannula contaminated once it has been used to enter or connect to a patient's intravenous infusion bag or administration set [453]. 
                       Category IB</p>
                      <p> IV.H.4. Use single-dose vials for parenteral medications whenever possible 
                       [453]. Category IA</p>
                       
                      <p> IV.H.5. Do not administer medications from single-dose vials or ampules to multiple patients or combine leftover contents for later use [369 453, 1005]. Category IA</p>
                      
                      <p> IV.H.6. If multidose vials must be used, both the needle or cannula and syringe used to access the multidose vial must be sterile [453, 1002]. 
                       Category IA</p>
                       
                      <p> IV.H.7. Do not keep multidose vials in the immediate patient treatment area and store in accordance with the manufacturer's recommendations; discard if sterility is compromised or questionable [453, 1003]. Category IA</p>
                      
                      <p> IV.H.8. Do not use bags or bottles of intravenous solution as a common source of supply for multiple patients 453, 1006. Category IB</p>
                      
                     </div>
                      
                      <p>   IV.I. Infection control practices for special lumbar puncture procedures Wear a surgical mask when placing a catheter or injecting material into the spinal canal or subdural space (i.e., during myelograms, lumbar puncture
                        and spinal or epidural anesthesia [906 907-909 910, 911 912-914, 918 1007]. Category IB                      </p>
                        
                     
                      <p> IV.J.
                      Worker safety adhere to federal and state requirements for protection of healthcare personnel from exposure to bloodborne pathogens [739]. Category IC</p>
                      <ul>
                        <li>See additional information on <a href="https://www.cdc.gov/injectionsafety/SpinalInjection-Meningitis.html">spinal injection procedures</a>.</li>
                      </ul>
                </div>
      
      <p class="topOPage"><a href="2007ip_part4.html#">Top of Page</a></p>
      
        <h3 id="a5">V. Transmission-Based Precautions</h3>
                  
                  <div class="margin"> 
                  <p>V.A. General principles</p>
                  
                  <div class="margin"> 
                  <p> V.A.1. In addition to Standard Precautions, use Transmission-Based Precautions for patients with documented or suspected infection or colonization with highly transmissible or epidemiologically-important pathogens for which additional precautions are needed to prevent 
                    transmission (see <a href="2007ip_appendA.html">Appendix A</a>) [24, 93, 126, 141, 306, 806, 1008]. Category IA</p>
                    
                  <p> V.A.2. Extend duration of Transmission-Based Precautions, (e.g., Droplet, Contact) for immunosuppressed patients with viral infections due to
                    prolonged shedding of viral agents that may be transmitted to
                    others [928, 931-933, 1009-1011].
                    Category IA
                  </p>
                  
                  </div>
                   <p> V.B. Contact Precautions</p>
                   
                   <div class="margin"> 
                   
<p>V.B.1. Use Contact Precautions as recommended in <a href="2007ip_appendA.html">Appendix A</a> for patients with known or suspected infections or evidence of syndromes that represent an increased risk for contact transmission. For specific recommendations for use of Contact Precautions for colonization or infection with MDROs, go to the <a href="../mdro/mdro_toc.html">MDRO guideline</a> [870].</p>

<p>V.B.2. Patient placement</p>

<div class="margin"> 

<p> V.B.2.a. In acute care hospitals, place patients who require Contact Precautions in a single-patient room when available [24, 687, 793, 796, 
  797, 806, 837, 893, 1012, 1013] Category IB 
  When single-patient rooms are in short supply, apply the following principles for making decisions on patient placement: </p>
  
<ul>
  <li> Prioritize patients with conditions that may facilitate 
    transmission (e.g., uncontained drainage, stool incontinence) for single-patient room placement. Category II </li>
  <li> Place together in the same room (cohort) patients who are infected or colonized with the same pathogen and are
    suitable roommates [29, 638, 808, 811-813, 815, 818, 819] Category IB</li>
  <li> If it becomes necessary to place a patient who requires Contact Precautions in a room with a patient who is not infected or colonized with the same infectious agent:
    <ul>
      <li>  Avoid placing patients on Contact Precautions in the same room with patients who have conditions that may increase the risk of adverse outcome from infection or that may facilitate transmission (e.g., those who are immunocompromised, have open wounds, or have anticipated prolonged lengths of stay). Category II</li>
      <li> Ensure that patients are physically separated (i.e., &gt;3 feet apart) from each other. Draw the privacy curtain between beds to minimize opportunities for direct contact.) Category II</li>
      <li> Change protective attire and perform hand hygiene between contact with patients in the same room, regardless of whether one or both patients 
        are on Contact Precautions [728, 741, 742, 988, 1014, 1015]. 
        Category IB</li>
      </ul>
  </li>
  </ul>
<p>  V.B.2.b. In long-term care and other residential settings, make decisions regarding patient placement on a case-by-case basis, balancing infection risks to other patients in the room, the presence of risk factors that increase the likelihood of transmission, and the 
  potential adverse psychological impact on the infected or colonized patient [920, 921]. Category II</p>
  
<p> V.B.2.c. In ambulatory settings, place patients who require Contact Precautions in an examination room or cubicle as soon as possible [20]. Category II 
                  </p>
                    
</div>
 <p>V.B.3. Use of personal protective equipment</p>
 
 <div class="margin"> 
 <p> V.B.3.a. Gloves Wear gloves whenever touching the patient's intact skin 24, 89, 134, 559, 746, 837 or surfaces and articles in close proximity to the patient (e.g., medical equipment, bed rails) 72, 73, 88, 837. Don gloves upon entry into the room or cubicle. Category IB</p>
 
 <p> V.B.3.b. Gowns</p>
 
 <div class="margin"> 
 <p> V.B.3.b.i. Wear a gown whenever anticipating that clothing will have direct contact with the patient or potentially contaminated environmental surfaces or equipment in close proximity to the patient. Don gown upon entry into the room or cubicle. Remove gown and observe hand hygiene before leaving the patient-care environment [24, 88,
   134, 745, 837]. Category IB</p>
   
 <p> V.B.3.b.ii. After gown removal, ensure that clothing and skin do not contact potentially contaminated environmental surfaces that could result in possible transfer of microorganism to other patients or environmental surfaces [72, 73]. Category II
 </p>
 
 </div>
 </div>
  <p> V.B.4. Patient transport</p>
  
  <div class="margin"> 
  <p> V.B.4.a. In acute care hospitals and long-term care and other residential settings, limit transport and movement of patients outside of the room to medically-necessary purposes. Category II</p>
  
  <p> V.B.4.b. When transport or movement in any healthcare setting is 
    necessary, ensure that infected or colonized areas of the 
    patient's body are contained and covered. Category II</p>
    
  <p> V.B.4.c. Remove and dispose of contaminated PPE and perform hand hygiene prior to transporting patients on Contact Precautions. 
    Category II</p>
    
  <p> V.B.4.d. Don clean PPE to handle the patient at the transport 
    destination. Category II 
  </p>
  
  </div>
    
    <p>V.B.5. Patient-care equipment and instruments/devices</p>
    
    
    <div class="margin"> 
    
    <p> V.B.5.a. Handle patient-care equipment and instruments/devices
      according to Standard Precautions [739, 836]. Category IB/IC</p>
      
    <p> V.B.5.b. In acute care hospitals and long-term care and other residential settings, use disposable noncritical patient-care equipment (e.g., blood pressure cuffs) or implement patient-dedicated use of such equipment. If common use of equipment for multiple patients is unavoidable, clean and disinfect such equipment
      before use on another patient [24, 88, 796, 836, 837, 854, 1016]. Category IB</p>
      
    <p> V.B.5.c. In home care settings</p>
    
    
    <div class="margin"> 
    
    <p> V.B.5.c.i. Limit the amount of non-disposable patient-care equipment brought into the home of patients on Contact Precautions. Whenever possible, leave patient-care equipment in the home until discharge from home care services. Category II</p>
    
    <p> V.B.5.c.ii. If noncritical patient-care equipment (e.g., stethoscope) cannot remain in the home, clean and disinfect items before taking them from the home using a low- to intermediate-level disinfectant. Alternatively, place contaminated reusable items in a plastic bag for transport and subsequent cleaning and disinfection. Category II</p>
    
    </div>
    
    <p> V.B.5.d. In ambulatory settings, place contaminated reusable noncritical patient-care equipment in a plastic bag for transport to a soiled utility area for reprocessing. Category II</p>
    
    </div>
    
    <p> V.B.6. Environmental measures Ensure that rooms of patients on Contact Precautions are prioritized for frequent cleaning and disinfection (e.g., at least daily) with a focus on frequently-touched surfaces (e.g., bed rails, overbed table, bedside commode, lavatory surfaces in patient bathrooms, doorknobs) and equipment in the immediate vicinity of
      the patient [11, 24, 88, 746, 837]. Category IB</p>
      
    <p> V.B.7. Discontinue Contact Precautions after signs and symptoms of the infection have resolved or according to pathogen-specific recommendations in <a href="2007ip_appendA.html">Appendix A</a>. Category IB
      
      </p>
                   </div>
                   
                    <p>V.C. Droplet Precautions</p>
                    
                    
                    <div class="margin">
                     
<p>                    V.C.1. Use Droplet Precautions as recommended in <a href="2007ip_appendA.html">Appendix A</a> for patients known or suspected to be infected with pathogens transmitted by respiratory droplets (i.e., large-particle droplets &gt;5&micro; in size) that are generated by a patient who is coughing, sneezing
                or talking [14, 23], Steinberg, [1969, 1708, 41, 95, 103, 111, 112, 755, 756, 989, 1017].
                Category IB</p>
                
<p> V.C.2. Patient placement</p>

<div class="margin"> 

<p> V.C.2.a. In acute care hospitals, place patients who require Droplet Precautions in a single-patient room when available Category II When single-patient rooms are in short supply, apply the following principles for making decisions on patient placement: </p>

<ul>

  <li>Prioritize patients who have excessive cough and sputum 
    production for single-patient room placement Category II </li>
    
  <li> Place together in the same room (cohort) patients who are infected the same pathogen and are suitable roommates [814 
    816]. Category IB</li>
    
  <li> If it becomes necessary to place patients who require Droplet Precautions in a room with a patient who does not have the same infection:</li>
  
  <li> Avoid placing patients on Droplet Precautions in the same room with patients who have conditions that may increase
    the risk of adverse outcome from infection or that may facilitate transmission (e.g., those who are immunocompromised, have or have anticipated prolonged lengths of stay). Category II</li>
    
  <li> Ensure that patients are physically separated (i.e., &gt;3 feet apart) from each other. Draw the privacy curtain between beds to minimize opportunities for close contact [103, 104 410].
    Category IB</li>
    
  <li>Change protective attire and perform hand hygiene between contact with patients in the same room, regardless of whether one patient or both patients are on Droplet
    Precautions [741-743, 988, 1014, 1015]. Category IB</li>
    
</ul>

<p> V.C.2.b. In long-term care and other residential settings, make decisions regarding patient placement on a case-by-case basis after considering infection risks to other patients in the room and available alternatives [410]. Category II</p>

<p>V.C.2.c. In ambulatory settings, place patients who require Droplet Precautions in an examination room or cubicle as soon as possible. Instruct patients to follow recommendations for Respiratory Hygiene/Cough Etiquette [447, 448 9, 828]. Category II</p>


</div>

<p> V.C.3. Use of personal protective equipment</p>

<div class="margin"> 
<p> V.C.3.a. Don a mask upon entry into the patient room or cubicle [14, 23, 41,
  103, 111, 113, 115, 827]. Category IB</p>
  
<p> V.C.3.b. No recommendation for routinely wearing eye protection (e.g., goggle or face shield), in addition to a mask, for close contact with patients who require Droplet Precautions. Unresolved issue</p>

<p> V.C.3.c. For patients with suspected or proven <a href="https://www.cdc.gov/ncidod/sars/">SARS</a>, <a href="https://www.cdc.gov/flu/avian/">avian influenza</a> or <a href="http://www.pandemicflu.gov/">pandemic influenza</a>, refer to the websites for the most current recommendations [134, 1018, 1019]</p>
  
</div>
  
  <p>V.C.4. Patient transport</p>
  
  <div class="margin"> 
  
 <p> V.C.4.a. In acute care hospitals and long-term care and other residential settings, limit transport and movement of patients outside of the room to medically-necessary purposes. Category II</p>
 
 <p> V.C.4.b. If transport or movement in any healthcare setting is necessary, instruct patient to wear a mask and follow <a href="../../flu/professionals/infectioncontrol/resphygiene.htm">Respiratory Hygiene/Cough Etiquette</a>. Category IB</p>
 
 <p> V.C.4.c. No mask is required for persons transporting patients on Droplet Precautions. Category II</p>
 
 <p> V.C.4.d. Discontinue Droplet Precautions after signs and symptoms have resolved or according to pathogen-specific recommendations in <a href="2007ip_appendA.html">Appendix A</a>. Category IB
   </p>
   
  </div>
                    </div>
                    
                <p>    V.D. Airborne Precautions</p>
                
                  <div class="margin"> 
                <p>   V.D.1. Use Airborne Precautions as recommended in <a href="2007ip_appendA.html">Appendix A</a> for patients known or suspected to be infected with infectious agents transmitted person-to-person by the airborne route (e.g., <em>M tuberculosis</em> [12], measles [34, 122, 1020], chickenpox [123, 773, 1021], disseminated herpes zoster [1022]. Category IA/IC</p>
                   
                <p> V.D.2. Patient placement</p>
                
                <div class="margin"> 
                
                <p> V.D.2.a. In acute care hospitals and long-term care settings, place patients who require Airborne Precautions in an AIIR that has been constructed in accordance with current guidelines 11-13. 
                  Category IA/IC</p>
                  
                  
                  <div class="margin"> 
                  
                <p> V.D.2.a.i. Provide at least six (existing facility) or [12] (new construction/renovation) air changes per hour.</p>
                
                <p> V.D.2.a.ii. Direct exhaust of air to the outside. If it is not possible to exhaust air from an AIIR directly to the outside, the air may be returned to the air-handling system or adjacent spaces if all air is directed through HEPA filters.</p>
                
                <p> V.D.2.a.iii. Whenever an AIIR is in use for a patient on Airborne Precautions, monitor air pressure daily with visual indicators (e.g., smoke tubes, flutter strips), regardless of the presence of differential pressure sensing devices (e.g., manometers) [11, 12, 1023, 1024].</p>
                
                <p> V.D.2.a.iv. Keep the AIIR door closed when not required for entry and exit.</p>
                
                </div>
                <p> V.D.2.b. When an AIIR is not available, transfer the patient to a facility that has an available AIIR [12]. Category II</p>
                
                <p> V.D.2.c. In the event of an outbreak or exposure involving large numbers of patients who require Airborne Precautions: </p>
                
                <ul>
                
                  <li> Consult infection control professionals before patient
                    placement to determine the safety of alternative room that do not meet engineering requirements for an AIIR.</li>
                  <li> Place together (cohort) patients who are presumed to have the same infection( based on clinical presentation and diagnosis when known) in areas of the facility that are away from other patients, especially patients who are at increased risk for infection (e.g., immunocompromised patients).</li>
                  
                  <li> Use temporary portable solutions (e.g., exhaust fan) to create a negative pressure environment in the converted area of the facility. Discharge air directly to the outside,away from people and air intakes, or direct all the air through HEPA filters before it is introduced to other air spaces [12] Category II</li>
                  
                </ul>
                
                <p> V.D.2.d. In ambulatory settings:</p>
                
                
                <div class="margin"> 
                
                <p> V.D.2.d.i. Develop systems (e.g., triage, signage) to identify patients with known or suspected infections that require Airborne Precautions upon entry into ambulatory settings 
                  [9, 12, 34, 127, 134]. Category IA</p>
                  
                <p> V.D.2.d.ii. Place the patient in an AIIR as soon as possible. If an AIIR is not available, place a surgical mask on the patient and place him/her in an examination room. Once the patient leaves, the room should remain vacant for the appropriate time, generally one hour, to allow for a full exchange of air [11, 12, 122]. Category IB/IC</p>
                
                <p> V.D.2.d.iii. Instruct patients with a known or suspected airborne infection to wear a surgical mask and observe Respiratory Hygiene/Cough Etiquette. Once in an AIIR, the mask may be removed; the mask should remain on if the patient is not in an AIIR [12, 107, 145, 899]. Category IB/IC</p>
                
                </div>
                
                </div>
                
                <p> V.D.3. Personnel restrictions Restrict susceptible healthcare personnel from entering the rooms of patients known or suspected to have measles (rubeola), varicella (chickenpox), disseminated zoster, or smallpox if other immune healthcare personnel are available [17, 775]. Category IB</p>
                
                <p> V.D.4. Use of PPE</p>
                
                <div class="margin"> 
                
                <p> V.D.4.a. Wear a fit-tested NIOSH-approved N95 or higher level respirator for respiratory protection when entering the room or home of a patient when the following diseases are suspected or confirmed:</p>
                
                <ul>
                
                  <li>Infectious pulmonary or laryngeal tuberculosis or when
                  infectious tuberculosis skin lesions are present and procedures that would aerosolize viable organisms (e.g., irrigation, incision and drainage, whirlpool treatments) are
                  performed [12, 1025, 1026]. Category IB</li>
                  
                  <li>Smallpox (vaccinated and unvaccinated). Respiratory protection is recommended for all healthcare personnel, including those with a documented &quot;take&quot; after smallpox vaccination due to the risk of a genetically engineered virus against which the vaccine may not provide protection, or of exposure to a very large viral load (e.g., from high-risk aerosol-generating procedures, immunocompromised patients, hemorrhagic or flat smallpox [108, 129]. Category II</li>
                </ul>
               
                <p> V.D.4.b. No recommendation is made regarding the use of PPE by healthcare personnel who are presumed to be immune to measles (rubeola) or varicella-zoster based on history of disease, vaccine, or serologic testing when caring for an individual with known or suspected measles, chickenpox or disseminated zoster, due to difficulties in establishing definite
                  immunity [1027, 1028]. Unresolved issue</p>
                  
                <p> V.D.4.c. No recommendation is made regarding the type of personal protective equipment (i.e., surgical mask or respiratory protection with a N95 or higher respirator) to be worn by susceptible healthcare personnel who must have contact with patients with known or suspected measles, chickenpox or disseminated herpes zoster. Unresolved issue</p>
                
                </div>
                
                <p> V.D.5. Patient transport</p>
                
                <div class="margin"> 
               
                <p> V.D.5.a. In acute care hospitals and long-term care and other residential settings, limit transport and movement of patients outside of the room to medically-necessary purposes. Category II</p>
                
                <p> V.D.5.b. If transport or movement outside an AIIR is necessary, instruct patients to wear a surgical mask, if possible, and observe Respiratory Hygiene/Cough Etiquette 12. Category II</p>
                
                <p> V.D.5.c. For patients with skin lesions associated with varicella or smallpox or draining skin lesions caused by M. tuberculosis, cover the affected areas to prevent aerosolization or contact with the infectious agent in skin lesions [108, 1025, 1026, 1029-1031]. 
                  Category IB</p>
                  
                <p> V.D.5.d. Healthcare personnel transporting patients who are on Airborne Precautions do not need to wear a mask or respirator during transport if the patient is wearing a mask and infectious skin lesions are covered. Category II</p>
                
                </div>
                
                <p>V.D.6. Exposure management Immunize or provide the appropriate immune globulin to susceptible persons as soon as possible following unprotected contact (i.e., exposed) to a patient with measles, varicella or smallpox: Category IA </p>
                
                <ul>
                
                  <li> Administer measles vaccine to exposed susceptible persons within 72 hours after the exposure or administer immune globulin within six days of the exposure event for high-risk persons in whom vaccine is contraindicated [17, 1032-1035].                    </li>
                  
                  <li>Administer varicella vaccine to exposed susceptible persons within 120 hours after the exposure or administer varicella immune globulin (VZIG or alternative product), when available, within 96 hours for high-risk persons in whom vaccine is contraindicated (e.g., immunocompromised patients, pregnant women, newborns whose mother's varicella onset was &lt;5 days before or within 48 hours after
                    delivery [888, 1035-1037]).</li>
                    
                  <li>Administer smallpox vaccine to exposed susceptible persons within 4 days after exposure [108, 1038-1040].</li>
                </ul>
                
                <p> V.D.7. Discontinue Airborne Precautions according to pathogen-specific recommendations in <a href="2007ip_appendA.html">Appendix A</a>. Category IB</p>
                
                
                <p> V.D.8. Consult CDC's &quot;<a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5417a1.htm">Guidelines for Preventing the Transmission of<em> Mycobacterium tuberculosis </em>in Health-Care Settings, 2005</a>&quot; [12] and the &quot;<a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5210a1.htm">Guideline for Environmental Infection Control in Health-Care Facilities</a>&quot; [11] for additional guidance on environment strategies for preventing transmission of tuberculosis in healthcare settings. The environmental recommendations in these guidelines may be applied to patients with other infections that require Airborne Precautions.</p>
                
                  </div>
                  </div>
       
       <p class="topOPage"><a href="2007ip_part4.html#">Top of Page</a></p>
       
        <h3 id="a6">VI. Protective Environment (Table 4)</h3>
                  
         <div class="margin">           
                    <p>VI.A. Place allogeneic hematopoietic stem cell transplant (HSCT) patients in a Protective Environment as described in the &quot;Guideline to Prevent Opportunistic Infections in HSCT Patients&quot; 15, the &quot;Guideline for Environmental Infection Control in Health-Care Facilities&quot; 11, and the &quot;<a href="../../mmwr/preview/mmwrhtml/rr5303a1.htm">Guidelines for Preventing Health-Care-Associated Pneumonia, 2003</a>&quot; 14 to reduce exposure to environmental fungi (e.g., Aspergillus sp) [157, 158]. Category IB</p>
                    <p> VI.B. No recommendation for placing patients with other medical conditions that are associated with increased risk for environmental fungal infections (e.g., aspergillosis) in a Protective Environment [11]. Unresolved issue</p>
                    
                    s<p>VI.C. For patients who require a Protective Environment, implement the following (see <a href="https://www.cdc.gov/hicpac/2007ip/2007ip_table5.html">Table 5</a>) [11, 15]</p>
                    
                    <div class="margin">  
                    
                    <p> VI.C.1. Environmental controls</p>
                    
                    <div class="margin">  
                    
                    <p> VI.C.1.a. Filtered incoming air using central or point-of-use high efficiency particulate (HEPA) filters capable of removing 99.97% of particles &gt;0.3 &micro;m in diameter 13. Category IB</p>
                    
                    <p>VI.C.1.b. Directed room airflow with the air supply on one side of the room that moves air across the patient bed and out through an exhaust on the opposite side of the room 13. Category IB</p>
                    
                    <p>VI.C.1.c. Positive air pressure in room relative to the corridor (pressure differential of &gt;12.5 Pa [0.01-in water gauge]) [13]. Category IB</p>
                   
                    <div class="margin">  
                    
                    
                    <p> VI.C.1.c.i. Monitor air pressure daily with visual indicators (e.g., smoke tubes, flutter strips) 11, 1024. Category IA</p>
                    
                    </div>
                    
                    <p>VI.C.1.d. Well-sealed rooms that prevent infiltration of outside air [13]. 
                      Category IB</p>
                    
                    <p>VI.C.1.e. At least 12 air changes per hour 13. Category IB</p>
                    
                    </div>
                    
                    <p>VI.C.2. Lower dust levels by using smooth, nonporous surfaces and finishes that can be scrubbed, rather than textured material (e.g., upholstery). Wet dust horizontal surfaces whenever dust detected and routinely clean crevices and sprinkler heads where dust may accumulate [940, 941]. Category II</p>
                    
                    <p> VI.C.3. Avoid carpeting in hallways and patient rooms in areas [941].
                      Category IB</p>
                    
                    <p>VI.C.4. Prohibit dried and fresh flowers and potted plants [942-944]. Category II</p>
                    
                    </div>
                    
                    <p>VI.D. Minimize the length of time that patients who require a Protective Environment are outside their rooms for diagnostic procedures and other 
                      activities [11, 158, 945]. Category IB</p>
                    
                    <p>VI.E. During periods of construction, to prevent inhalation of respirable particles that could contain infectious spores, provide respiratory protection (e.g., N95 respirator) to patients who are medically fit to tolerate a respirator when they are required to leave the Protective Environment [945 158]. 
                      Category II</p>
                      
                      <div class="margin">  
                    
                    <p> VI.E.1.a. No recommendation for fit-testing of patients who are using respirators. Unresolved issue</p>
                    
                    <p> VI.E.1.b. No recommendation for use of particulate respirators when leaving the Protective Environment in the absence of construction. Unresolved issue</p>
                    
                    </div>
                    
                    <p>VI.F. Use of Standard and Transmission-Based Precautions in a Protective Environment.</p>
                   
                    <div class="margin">  
                    
                    <p> VI.F.1. Use Standard Precautions as recommended for all patient 
                      interactions. Category IA</p>
                    
                    <p>VI.F.2. Implement Droplet and Contact Precautions as recommended for diseases listed in <a href="2007ip_appendA.html">Appendix A</a>. Transmission-Based precautions for viral infections may need to be prolonged because of the patient's immunocompromised state and prolonged shedding of viruses [930 
                      1010 928, 932 1011]. Category IB</p>
                    
                    <p> VI.F.3. Barrier precautions, (e.g., masks, gowns, gloves) are not required for healthcare personnel in the absence of suspected or confirmed infection in the patient or if they are not indicated according to Standard Precautions 15. Category II</p>
                   
                    <p> VI.F.4. Implement Airborne Precautions for patients who require a Protective Environment room and who also have an airborne infectious disease (e.g., pulmonary or laryngeal tuberculosis, acute varicella-zoster). Category IA 
                      </p>
                      
                      
                      <div class="margin">  
                      
                    <p>VI.F.4.a. Ensure that the Protective Environment is designed to maintain positive pressure 13. Category IB </p>
                    <p> VI.F.4.b. Use an anteroom to further support the appropriate air-balance relative to the corridor and the Protective Environment; provide independent exhaust of contaminated air to the outside or place a HEPA filter in the exhaust duct if the return air must be recirculated 13, 1041. Category IB </p>
                    
                    
                    <p>VI.F.4.c. If an anteroom is not available, place the patient in an AIIR and use portable, industrial-grade HEPA filters in the room to enhance filtration of spores 1042. Category II </p>
         </div>
         </div>
         </div>
        
        <p class="topOPage"><a href="2007ip_part4.html#">Top of Page</a></p>
        
        </div>
        </div>
        
    			  <!-- InstanceEndEditable -->
					<!-- /end .main-inner --></div>
					
					<div id="linkPolicy">&nbsp;</div>
				<!-- /end #content-main--></div>
				
			<!-- /end #content-inner --></div>
			
			<!-- ########## RIGHT COLUMN STARTS HERE ########## -->
			<div id="content-secondary">
				<div class="pageOptions">
					<div class="pageOptions-inner">
						<ul id="services" class="services">
							<li class="print"><a href="javascript:window.print();" title="Print page.">Print page</a></li>
						</ul>
						<!-- InstanceBeginEditable name="local-options" -->
                        
                        <ul class="services top-divide">
						  <li class="pdf"><a class="noDecoration" href="https://www.cdc.gov/hicpac/pdf/isolation/Pages74_92_Isolation2007.pdf" title="PDF  188 KB">Download page</a></li>
					    </ul>
                        
					
					<!-- InstanceEndEditable --><!-- InstanceBeginEditable name="languages" -->				<!-- InstanceEndEditable -->
					</div>
				</div>
				
				
				<!-- InstanceBeginEditable name="gov-delivery" -->
			  
			<!-- InstanceEndEditable -->
				<!-- InstanceBeginEditable name="contact-info" -->
			<div id="contact-info">
	<h5>Contact Us:</h5>
	<ul class="noBullet">
		<li class="mail">Centers for Disease Control and Prevention<br />
		1600 Clifton Rd<br />
		Atlanta, GA 30333</li>
		<li class="phone">800-CDC-INFO<br />
		(800-232-4636)<br />
		TTY: (888) 232-6348</li>
		<li><a href="../../cdc-info/requestform.html">Contact CDC&ndash;INFO</a></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
			<!-- /end #content-secondary --></div>
			
			<!-- ########## LEFT NAVIGATION STARTS HERE ########## -->
			<div id="nav-container"><!-- InstanceBeginEditable name="left-nav-include" --> <div id="nav">
  <h3><a href="../index.html">HICPAC</a></h3>
	<ul id="nav-primary">
    <li><a href="../about.html">About HICPAC</a></li>
    <li><a href="../roster.html">Member Roster</a></li>
    <li><a href="../charter.html">Charter</a> </li>
    <li><a href="../eCalendar.html">Event Calendar</a>
      <!--ul>
        <li><a href="/hicpac/agenda.html">Meeting Agenda</a></li>  
      </ul-->
    </li>
    <li><a href="../guidelineMethod/guidelineMethod.html">Methodology Guideline</a>
      <ul>
        <li><a href="../guidelineMethod/001_methods_background.html">Background</a></li>
        <li><a href="../guidelineMethod/002_methods_emergingNeeds.html">Strengthening HICPAC Guidelines to Address Emerging Needs</a></li>
        <li><a href="../guidelineMethod/003_methods_Organiz2AccomplishGoals.html">Organizing to Accomplish Our Goals</a> </li>
        <li><a href="../guidelineMethod/004_methods_guidelineDevelopment.html">Methods in Guideline Development</a></li>
        <li><a href="../guidelineMethod/005_methods_challengesOpportunities.html">Looking to Future Challenges and Opportunities</a></li>
        <li><a href="../guidelineMethod/007_methods_References.html">References</a></li>
        <li><a href="../guidelineMethod/008_methods_tables.html">Tables</a></li>
        <li><a href="../guidelineMethod/011_methods_figures.html">Figures</a></li>
      </ul>
    </li>
	<!--li><a href="/hicpac/projects_in_progress.html">Projects in Progress</a></li-->
	<li><a href="../pubs.html">Publications</a>
			<ul>
			  <li><a href="../BSI/BSI-guidelines-2011.html">2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections</a>
		        <ul>
		          <li><a href="../BSI/toc-BSI-guidelines-2011.html">Table of Contents</a></li>
		          <li><a href="../BSI/01-BSI-guidelines-2011.html">Notice to Readers</a> </li>
		          <li><a href="../BSI/02-bsi-summary-of-recommendations-2011.html">Summary Of Recommendations</a> </li>
		          <li><a href="../BSI/03-bsi-summary-of-recommendations-2011.html">Patient Cleansing 
		            </a></li>
		          <li><a href="../BSI/04-bsi-background-info-2011.html">Background Information</a></li>
		          <li><a href="../BSI/05-bsi-background-info-2011.html">Maximal Sterile Barrier Precautions 
		            </a></li>
		          <li><a href="../BSI/06-bsi-background-info-2011.html">Antibiotic Lock Prophylaxis, Antimicrobial Catheter Flush and Catheter Lock Prophylaxis 
		            </a></li>
		          <li><a href="../BSI/07-bsi-background-info-2011.htmles-2011.html">Replacement of Administration Sets</a></li>
		          <li><a href="../BSI/bsi-table-1-2011.html">Table 1. Catheters used for venous and arterial access</a></li>
		          <li><a href="../BSI/13-references-BSI-guidelines-2011.html">References</a></li>
		          <li><a href="../BSI/11-appendix-B-BSI-guidelines-2011.html">Appendix B. Disclosure of financial interests or relationships</a></li>
		          <li><a href="../BSI/12-appendix-C-BSI-guidelines-2011.html">Appendix C. Summary of Recommendations</a></li>
	            </ul>
			  </li>
		      <li><a href="../norovirus/002_norovirus-toc.html">2011 Norovirus Guidelines
		        </a>
		        <ul>
		          <li><a href="../norovirus/003_norovirus-abbreviations.html">Abbreviations</a></li>
					   
					   <li><a href="../norovirus/001_norovirus.html">Acknowledgement</a></li>
					   <li><a href="../norovirus/004_norovirus-exec-summary.html">Executive Summary</a></li>
					   <li><a href="../norovirus/005_norovirus-summaryOrecs.html">Summary of Recommendations</a></li>
					   <li><a href="../norovirus/006_norovirus-implement-audit.html">Implementation and Audit</a> </li>
					   <li> <a href="../norovirus/007_norovirus-recs-further-research.html">Recommendations for Further Research					     </a></li>
					   <li><a href="../norovirus/008_norovirus-background.html">Background					     </a></li>
					   <li><a href="../norovirus/009_norovirus-scope.html">Scope and Purpose</a> </li>
					   <li><a href="../norovirus/010_norovirus-methods.html">Methods</a> </li>
					   <li><a href="../norovirus/011_norovirus-evidence-review.html">Evidence Review Question 1</a>				       </li>
                       <li><a href="../norovirus/012_norovirus-evidence-q2.html">Question 2</a></li>
                       <li><a href="../norovirus/013_norovirus-evidence-q3.html">Question 3</a></li>
                  <li><a href="../norovirus/norovirus-appendix-1.html">Appendix 1</a></li>
                       <li><a href="../norovirus/norovirus-appendix-1b.html">Appendix 1B</a> </li>
                       <li><a href="../norovirus/tables/evidence-Table1.html">Evidence, Grade &amp; Study Quality Assessment Tables</a></li>
                  <li><a href="../norovirus/norovirus-appendix-3.html">Appendix 3</a></li>
                       <li><a href="../norovirus/norovirus-appendix-4.html">Appendix 4</a></li>
                       <li><a href="../norovirus/norovirus-references.html">References</a></li>
		        </ul>
		      </li>
	          <li><a href="../Disinfection_Sterilization/acknowledg.html">2008 Disinfection &amp; Sterilization Guideline</a>               
	            <ul>
	              <li><a href="../Disinfection_Sterilization/toc.html">Table of Contents</a></li>
	              <li><a href="../Disinfection_Sterilization/1_sumIntroMethTerms.html">Executive Summary</a> </li>
	              <li><a href="../Disinfection_Sterilization/2_approach.html">Approach to Disinfection and Sterilization</a> 
	                  <ul>
	                    <li><a href="../Disinfection_Sterilization/3_0disinfectEquipment.html">Disinfection of Healthcare Equipment</a></li>
                        <li><a href="../Disinfection_Sterilization/3_1deLaparoArthro.html">Laparoscopes and Arthroscopes</a> </li>
                        <li><a href="../Disinfection_Sterilization/3_2contaminatedDevices.html">Disinfection of HBV, HCV, HIV or TB-Contaminated Devices</a></li>
                        <li><a href="../Disinfection_Sterilization/3_3inactivBioAgents.html">Inactivation of Bioterrorist Agents</a></li>
                        <li><a href="../Disinfection_Sterilization/3_4surfaceDisinfection.html">Surface Disinfection</a></li>
                    </ul>
	              </li>
                  <li><a href="../Disinfection_Sterilization/4_0efficacyDS.html">Factors Affecting The Efficacy Of Disinfection And Sterilization</a></li>
                  <li><a href="../Disinfection_Sterilization/5_0cleaning.html">Cleaning</a></li>
                  <li><a href="../Disinfection_Sterilization/6_0disinfection.html">Disinfection</a>
                    <ul>
                      <li><a href="../Disinfection_Sterilization/7_0formaldehyde.html">Formaldehyde</a></li>
                      <li><a href="../Disinfection_Sterilization/8_0Iodophors.html">Iodophors</a></li>
                      <li><a href="../Disinfection_Sterilization/9_0PceticAcidHydroPoxide.html">Peracetic Acid and Hydrogen Peroxide</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/10_0MiscAgents.html">Miscellaneous Inactivating Agents</a></li>
                  <li><a href="../Disinfection_Sterilization/11_0regulatory_Framework.html">Regulatory Framework for Disinfectants and Sterilants</a></li>
                  <li><a href="../Disinfection_Sterilization/13_0Sterilization.html">Sterilization</a>
                      <ul>
	                      
                        <li><a href="../Disinfection_Sterilization/13_02sterilization.html">Low-Temperature Sterilization Technologies</a></li>
		                          
                        <li><a href="../Disinfection_Sterilization/13_06PeraceticAcidSterilization.html">Peracetic Acid Sterilization</a></li>
		                         
                        <li><a href="../Disinfection_Sterilization/13_10otherSterilizationMethods.html">Other Sterilization Methods</a></li>
                        <li><a href="../Disinfection_Sterilization/13_11sterilizingPractices.html">Sterilizing Practices</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/14_00ReuseMedicalDevices.html">Reuse of Single-Use Medical Devices</a></li>
                  <li><a href="../Disinfection_Sterilization/17_00Recommendations.html">Recommendations for Disinfection and Sterilization in Health-Care Facilities</a></li>
                  <li><a href="../Disinfection_Sterilization/18_00PerformanceIndicators.html">Performance Indicators</a></li>
                  <li><a href="../Disinfection_Sterilization/19_00glossary.html">Glossary</a></li>
                  <li><a href="../Disinfection_Sterilization/table_1.html">Tables &amp; Figure</a>
                    <ul>
                      <li><a href="../Disinfection_Sterilization/table_2.html">Table 2, 3</a></li>
                      <li><a href="../Disinfection_Sterilization/fig_1.html">Figure 1</a></li>
                      <li><a href="../Disinfection_Sterilization/table_4.html">Table 4</a></li>
                      <li><a href="../Disinfection_Sterilization/table_5.html">Table 5</a></li>
                      <li><a href="../Disinfection_Sterilization/table_6.html">Table 6</a></li>
                      <li><a href="../Disinfection_Sterilization/table_7.html">Table 7, 8, 9</a></li>
                      <li><a href="../Disinfection_Sterilization/table_10.html">Table 10, 11, 12</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/20_00reference.html">References</a></li>
                </ul>
              </li>
	          <li><a href="2007isolationPrecautions.html">Guideline for Isolation Precautions 2007</a>
				  <ul>
                        <li><a href="2007ip_ExecSummary.html">Executive Summary</a></li>
                        <li> <a href="2007ip_part1.html">Part I: Review of Scientific Data Regarding Transmission of Infectious Agents in Healthcare Settings</a></li>
                        <li><a href="2007ip_part2.html">Part II: Fundamental elements needed to prevent transmission of infectious agents in healthcare settings</a></li>
                        <li><a href="2007ip_part3.html">Part III: Precautions to Prevent Transmission of Infectious Agents</a></li>
                        <li><a href="2007ip_part4.html">Part IV: Recommendations</a></li>
                        <li><a href="2007ip_appendA.html">Appendix A</a></li>
                        <li><a href="2007ip_tables.html">Tables 1 - 5</a>
                          <ul>
                            <li><a href="2007ip_table2.html">Table 2</a></li>
                            <li><a href="2007ip_table3.html">Table 3</a></li>
                            <li><a href="2007ip_table4.html">Table 4</a></li>
                            <li><a href="2007ip_table5.html">Table 5</a></li>
                          </ul>
                        </li>
                        <li><a href="2007ip_fig.html">Figure. Example of Safe Donning and Removal of PPE</a></li>
                        <li><a href="2007ip_glossary.html">Glossary</a></li>
                        <li><a href="2007ip_reference.html">References</a></li>
                </ul>
			  </li>
			    
	            <li><a href="../cauti/001_cauti.html">2009 CAUTI Guideline</a>
	              <ul>
	                <li><a href="../cauti/002_cauti_toc.html">Table of Contents</a>
	                  <!--<ul><li><a href="/hicpac/Disinfection_Sterilization/1_sumIntroMethTerms-levi.html">test</a></li></ul>-->
                    </li>
                      <li><a href="../cauti/02_cauti2009_abbrev.html">Abbreviations</a></li>
                      <li><a href="../cauti/003_cauti2009_execSum.html">I. Executive Summary</a></li>
                      <li><a href="../cauti/002_cauti_sumORecom.html">II. Summary of Recommendations</a></li>
                      <li><a href="../cauti/003_ImplementAudit.html">III. Implementation and Audit</a></li>
                      <li><a href="../cauti/004_furtherResearch.html">IV. Recommendations for Further Research</a></li>
                      <li><a href="../cauti/005_background.html">V. Background</a></li>
                      <li><a href="../cauti/006_scopePurpose.html">VI. Scope and Purpose</a></li>
                      <li><a href="../cauti/007_methods.html">VII. Methods</a></li>
                      <li><a href="../cauti/008_evidenceReview.html">VIII. Evidence Review</a></li>
                      <li><a href="../cauti/009_cauti2009_References.html">References</a></li>
                      <li><a href="../cauti/010_cauti2009_figs.html">Figures</a></li>
		          </ul>
              </li>
              
              <li><a href="../CAUTI_fastFacts.html">CAUTI Guideline Fast Facts</a></li>
              <li><a href="../uti_saint_video.html">Podcast: Dr. Sanjay Saint discusses CAUTIs</a></li>
              <li><a href="../mdro/mdro_0.html">Management of MDRO's in Healthcare Settings</a>
	          <ul>
	            <li><a href="../mdro/mdro_toc.html">Table of Contents</a></li>
	            <li><a href="../mdro/mdro_1.html">Introduction</a></li>
	            <li><a href="../mdro/mdro_2.html">Background</a></li>
	            <li><a href="../mdro/mdro_3.html">Epidemiology of MDROs</a></li>
	            <li><a href="../mdro/mdro_4.html">MDRO Prevention and Control</a></li>
	            <li><a href="../mdro/mdro_4_1.html">Discussion</a></li>
	            <li><a href="../mdro/mdro_5.html">Prevention of transmission of Multidrug Resistant Organisms </a></li>
	            <li><a href="../mdro/mdro_table1.html">Tables 1-2</a></li>
	            <li><a href="../mdro/mdro_table3.html">Table 3</a> </li>
	            <li><a href="../mdro/mdro_glossary.html">Glossary - Multidrug-Resistant Organisms</a></li>
	            <li><a href="../mdro/mdro_reference.html">References</a></li>
              </ul>
	        </li>
	        <li><a href="../pubReportGuide/publicReportingHAI.html">Guidance on Public Reporting of HAIs 2003</a>
			      <ul>
			        <li><a href="../pubReportGuide/prg_tbl1.html">Table 1</a></li>
		            <li><a href="../pubReportGuide/prg_tbl2.html">Table 2</a></li>
                    <li><a href="../pubReportGuide/prHAI_reference.html">Reference</a></li>
	              </ul>
		      </li>
            <li><a href="../SSI/001_SSI.html">Guideline for Prevention of Surgical Site Infection, 1999 </a>
              <ul>
                <li><a href="../SSI/toc_SSI.html"> Table of contents</a></li>
                
                <li><a href="../SSI/002_SSI.html">Surgical Site Infection (SSI): An Overview</a></li>
                <li><a href="../SSI/003_SSI.html">Microbiology</a></li>
                <li><a href="../SSI/004_SSI.html"> Operative characteristics: Preoperative issues                                 </a></li>
                <li><a href="../SSI/005_SSI.html">Operative characteristics: Intraoperative issues 
                                 </a></li>
                <li><a href="../SSI/006_SSI.html">SSI Surveillance </a></li>
                <li><a href="../SSI/007_SSI.html">Recommendations for Prevention of SSI</a></li>
                <li><a href="../SSI/ref-SSI.html">References </a></li>
                <li><a href="../SSI/figure-SSI.html">Figure</a></li>
                <li><a href="../SSI/table1-SSI.html">Table 1</a></li>
                <li><a href="../SSI/table2-SSI.html">Table 2</a></li>
                <li><a href="../SSI/table3-SSI.html">Table 3</a></li>
                <li><a href="../SSI/table4-SSI.html">Table 4</a></li>
                <li><a href="../SSI/table5-SSI.html">Table 5</a></li>
                <li><a href="../SSI/table6-SSI.html">Table 6</a></li>
                <li><a href="../SSI/table7-8-9-10-SSI.html">Table 7-8-9-10</a></li>
              </ul>
            </li>
            <li><a href="../Pubs/Antibiotic-Stewardship-Statement.html">Antibiotic Stewardship Statement for Antibiotic Guidelines, 2016</a></li>
      </ul>
	  </li>
       
	<li><a href="../presentations.html">Proceedings &amp; Presentations</a>
	  <!--ul>
	    <li><a href="/hicpac/transcript-07-23.html">July 09 - Interim Guidance for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
        <li><a href="/hicpac/h1n12009.html">Summary of Recommendations for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
	  </ul-->
	</li>
   
    <!--li><a href="/hicpac/registration.html">HICPAC Online Registration</a></li-->
    <li><a href="../contact.html">Contact HICPAC</a></li>
  </ul>
</div>
<div class="bottom"></div>

               
			  
             
				<!-- InstanceEndEditable -->
			</div>
			
		<!-- /end #content --></div>
		
		<div class="preFoot">
			<div id="plugin-legend">
			<h3>File Formats Help:</h3>
			<ul>
				<li class="plugin-pdf"><a href="../../Other/plugins/index.html#pdf"><img src="../../TemplatePackage/images/icon_pdf.gif" alt="Adobe PDF file" /></a></li>
				<li class="plugin-word"><a href="../../Other/plugins/index.html#doc"><img src="../../TemplatePackage/images/icon_word.gif" alt="Microsoft Word file" /></a></li>
				<li class="plugin-excel"><a href="../../Other/plugins/index.html#xls"><img src="../../TemplatePackage/images/icon_excel.gif" alt="Microsoft Excel file" /></a></li>
				<li class="plugin-ppt"><a href="../../Other/plugins/index.html#ppt"><img src="../../TemplatePackage/images/icon_ppt.gif" alt="Microsoft PowerPoint file" /></a></li>
				<li class="plugin-wmv"><a href="../../Other/plugins/index.html#wmv"><img src="../../TemplatePackage/images/icon_wmv.gif" alt="Audio/Video file" /></a></li>
				<li class="plugin-zip"><a href="../../Other/plugins/index.html#zip"><img src="../../TemplatePackage/images/icon_zip.gif" alt="Zip Archive file" /></a></li>
				<li class="plugin-real"><a href="../../Other/plugins/index.html#ram"><img src="../../TemplatePackage/images/icon_real.gif" alt="RealPlayer file" /></a></li>
				<li class="plugin-qt"><a href="../../Other/plugins/index.html#qt"><img src="../../TemplatePackage/images/icon_qt.gif" alt="Apple Quicktime file" /></a></li>
			</ul>
			<p><a href="../../Other/plugins/index.html"><span class="tp-label">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</span>&nbsp;<img src="../../TemplatePackage/images/btn_dblArrows.gif" alt="double arrows." /></a></p>
		</div>
			<div class="pageOptions-horizontal">
				<ul class="services">
					<li class="print"><a href="javascript:window.print();">Print</a></li>
<!-- InstanceBeginEditable name="local-options-horizontal" -->
				<!--<li class="pdf"><a href="">Download</a></li>-->
				 
				<!--<li class="rss"><a href="">Subscribe</a></li>-->
				<!-- InstanceEndEditable -->
				</ul>
			</div>
			<div id="datestamp"><!-- InstanceBeginEditable name="date-stamp" -->
			 <div class="syndicate">  
    <div class="mSyndicate">  
            
            <ul>
				<li class="last-reviewed">Page last reviewed: <span>December 29, 2009</span></li>
				<li class="last-updated">Page last updated: October 25, 2011</li>
			  <li class="content-source">Content source: <a href="../../index.html">Centers for Disease Control and Prevention</a><br /> <a href="../../ncezid.1.html">National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)</a><br /> <a href="../../ncezid/dhqp/index.html">Division of Healthcare Quality Promotion (DHQP)</a></li>

		</ul>
        
        </div>
        </div>
		<!-- InstanceEndEditable -->
			</div>
			
		</div>
		<div id="siteinfo">
	<div id="siteinfo-nav">
		<ul class="menu">
			<li><a href="../../index.html">Home</a></li>
			<li><a href="../../az/a.html">A-Z Index</a></li>
			<li><a href="../../Other/policies.html">Policies</a></li>
			<li><a href="../../Other/about_cdcgov.html">Using this Site</a></li>
			<li><a href="../../Other/link.html">Link to Us</a></li>
			<li class="last-child"><a href="../../contact.1.html">Contact CDC</a></li>
		</ul>
	</div>
	<div id="siteinfo-credits">
		<div id="siteinfo-logos"><a href="https://www.usa.gov//"><img id="logo_usagov" src="../../TemplatePackage/images/logo_usagov.gif" alt="USA.gov: The U.S. Government's Official Web Portal" width="188" height="55" border="0" /></a><a href="https://www.hhs.gov/"><img id="logo_dhhs" src="../../TemplatePackage/images/logo_dhhs.gif" alt="Department of Health and Human Services" width="61" height="55" border="0" /></a></div>
		<address>Centers for Disease Control and Prevention &nbsp; 1600 Clifton Road Atlanta, GA 30329-4027, USA<br />
		800-CDC-INFO (800-232-4636)	TTY: (888) 232-6348 - <a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx">Contact CDC&ndash;INFO</a></address>
	</div>
</div>

<!--include virtual="/TemplatePackage/3.0/includes/interstitialModal.html" -->
		
		<div id="AZlist-container"><a name="az"></a>
	<span>A-Z Index</span>
	<ol class="AZlist">
		<li><a href="../../az/a.html">A</a></li>
		<li><a href="../../az/b.html">B</a></li>
		<li><a href="../../az/c.html">C</a></li>
		<li><a href="../../az/d.html">D</a></li>
		<li><a href="../../az/e.html">E</a></li>
		<li><a href="../../az/f.html">F</a></li>
		<li><a href="../../az/g.html">G</a></li>
		<li><a href="../../az/h.html">H</a></li>
		<li><a href="../../az/i.html">I</a></li>
		<li><a href="../../az/j.html">J</a></li>
		<li><a href="../../az/k.html">K</a></li>
		<li><a href="../../az/l.html">L</a></li>
		<li><a href="../../az/m.html">M</a></li>
		<li><a href="../../az/n.html">N</a></li>
		<li><a href="../../az/o.html">O</a></li>
		<li><a href="../../az/p.html">P</a></li>
		<li><a href="../../az/q.html">Q</a></li>
		<li><a href="../../az/r.html">R</a></li>
		<li><a href="../../az/s.html">S</a></li>
		<li><a href="../../az/t.html">T</a></li>
		<li><a href="../../az/u.html">U</a></li>
		<li><a href="../../az/v.html">V</a></li>
		<li><a href="../../az/w.html">W</a></li>
		<li><a href="../../az/x.html">X</a></li>
		<li><a href="../../az/y.html">Y</a></li>
		<li><a href="../../az/z.html">Z</a></li>
		<li><a href="../../az/0.html">#</a></li>
	</ol>
</div>

	<!-- /end #wrapper-inner --></div>
	
<!-- /end #wrapper --></div>

<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- SiteCatalyst code version: H.21. -->
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/topic_levels.js"></script>
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script language="JavaScript" type="text/javascript">

<!-- InstanceBeginEditable name="metrics" -->
s.pageName=document.title;
s.channel="HICPAC";

siteCatalyst.setLevel1("NCEZID"); 
siteCatalyst.setLevel2("DHQP"); 
siteCatalyst.setLevel3("Healthcare Infection Control Practices Advisory Committee"); 
<!-- InstanceEndEditable -->
s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();if(s_code)document.write(s_code);//--></script>
<script language="JavaScript" type="text/javascript"><!--
if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-');
//--></script><noscript><a href="http://www.omniture.com" title="Web Analytics"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" border="0" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->



</body>
<!-- InstanceEnd --></html>